CIK 0000921114
- Non-accelerated filer
- Smaller reporting company
Armata Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ARMP
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 911549568
- Phone
- +1 310-665-2928
- Business address
- 5005 MCCONNELL AVE, LOS ANGELES, CA, 90066
- Former names
- AmpliPhi Biosciences Corp, TARGETED GENETICS CORP /WA/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 22 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-10 | Birx Deborah Chief Executive Officer | Shares withheld for taxes | −14,041 | $4.26 | $60K | 198,417 |
| 2026-03-14 | Birx Deborah Chief Executive Officer | Shares withheld for taxes | −4,919 | $10.54 | $52K | 212,458 |
| 2026-03-09 | Birx Deborah Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +421,226 | 421,226 | ||
| 2025-07-10 | Birx Deborah Chief Executive Officer | Shares withheld for taxes | −13,637 | $2.27 | $31K | 217,377 |
| 2025-03-14 | Birx Deborah Chief Executive Officer | Shares withheld for taxes | −6,061 | $1.95 | $12K | 231,014 |
| 2025-02-05 | Birx Deborah Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +240,000 | 240,000 | ||
| 2024-07-10 | Birx Deborah Chief Executive Officer | Shares withheld for taxes | −22,925 | $2.68 | $61K | 237,075 |
| 2024-03-14 | Birx Deborah Chief Executive Officer | Grant or award | +60,000 | 260,000 | ||
| 2024-03-14 | Birx Deborah Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +240,000 | 240,000 | ||
| 2023-12-21 | Birx Deborah Chief Executive Officer | Grant or award | +200,000 | 200,000 | ||
| 2023-12-21 | Birx Deborah Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +200,000 | 200,000 |
Page 1 of 1 · 11 trades